A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
2223-001
Phase 1 other active
Quick answer
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma for T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL) is a Phase 1 program (other) at Kyowa Kirin Holdings B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kyowa Kirin Holdings B.V.
- Indication
- T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)
- Phase
- Phase 1
- Modality
- other
- Status
- active